Measles in Indonesia: Vaccination Coverage and Identified Challenges
Keywords:
Measles, Measles resurgence, Immunization coverage, Indonesia, Vaccine hesitancy, Public health systemsAbstract
Measles has re-emerged as a significant public health threat in Indonesia, signaling gaps in immunization coverage and systemic health inequities. Following the disruptions caused by the COVID-19 pandemic, the country has seen a troubling resurgence in cases. This editorial examines the current epidemiological situation, structural barriers to vaccination, and necessary strategies for elimination. In 2025, Indonesia recorded over 63,000 suspected cases, with the trend continuing into 2026. Current vaccination coverage for children aged 12–23 months stands at 73.46%, which is significantly below the 95% threshold required for herd immunity. Key barriers identified include maternal education levels, archipelagic geography, and sociocultural factors such as religious permissibility and safety concerns. Addressing the measles resurgence requires a multi-faceted approach: strengthening routine and catch-up immunization services, addressing social determinants of health, and rebuilding public trust through community engagement. Achieving high coverage is essential to prevent severe clinical complications and protect vulnerable populations.References
Indonesian Ministry of Health (2026)
Indonesian Pediatric Society (IDAI) outbreak data (2025–2026)
Guerra F, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. The Lancet Infectious Disease. 2017;17(12):E420-28.
Fu H, Abbas K, Klepac P, et al. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries BMC Medicine. 2021;19:281.
Hermawan A, Irawan IR, Widiyanti M, et al. Association of socio-demographic factors with measles vaccination coverage among Indonesian children aged 12-23 months: a nationwide study. Turkish Journal of Pediatrics. 2025;67(3):304–16.
Chu H, Rammohan A. Childhood immunization and age-appropriate vaccinations in Indonesia. BMC Public Health. 2023;22.
Salleh H, Avoi R, Karim HA. Community-based intervention to improve measles vaccination completion in marginalised community settlements in Kota Kinabalu, Sabah: a cluster randomised control trial. BMC Infectious Diseases. 2025:25:514.
Murphy AA, Indah R, Wagner AL, Understanding the influence of religious and safety concerns on childhood measles and pertussis vaccination: a study conducted in Aceh, Indonesia. BMC Infectious Diseases. 2025;25.
Yitbarek K, Mahimbo A, Bobo FT, et al. Impact of measles vaccination strategies on vaccination rates in LMICs: A systematic review and meta-analysis. BMJ Global Health. 2025;10(2):e016647.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Erni J Nelwan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
